First patient dosed in landmark trial for GAD treatment
Category: News
New treatment could revolutionise care for HAE patients
Phase 2a study shows promising antidepressant effects
Trial explores potential of therapy in treating multiple cancer types
Promising trial results support marketing authorisation application
Successful phase 1 study highlights potential of roginolisib
Promising results set stage for European marketing authorization
New cell therapy shows potential in treating advanced blood disorder
New findings presented at international SCWD conference